258 related articles for article (PubMed ID: 1446617)
1. Effects of coadministered growth hormone (GH)-releasing hormone and GH-releasing hexapeptide on maladaptive aspects of obesity in Zucker rats.
Bercu BB; Yang SW; Masuda R; Hu CS; Walker RF
Endocrinology; 1992 Dec; 131(6):2800-4. PubMed ID: 1446617
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat.
Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC
Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945
[TBL] [Abstract][Full Text] [Related]
3. Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone.
Bercu BB; Yang SW; Masuda R; Walker RF
Endocrinology; 1992 May; 130(5):2579-86. PubMed ID: 1315249
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat.
Locatelli V; Grilli R; Torsello A; Cella SG; Wehrenberg WB; Müller EE
Pediatr Res; 1994 Aug; 36(2):169-74. PubMed ID: 7970930
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
[TBL] [Abstract][Full Text] [Related]
6. Robust growth hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH).
Walker RF; Yang SW; Bercu BB
Life Sci; 1991; 49(20):1499-504. PubMed ID: 1943453
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
[TBL] [Abstract][Full Text] [Related]
8. On the actions of the growth hormone-releasing hexapeptide, GHRP.
Bowers CY; Sartor AO; Reynolds GA; Badger TM
Endocrinology; 1991 Apr; 128(4):2027-35. PubMed ID: 2004615
[TBL] [Abstract][Full Text] [Related]
9. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats.
De Gennaro-Colonna V; Rossoni G; Cocchi D; Rigamonti AE; Berti F; Muller EE
J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647
[TBL] [Abstract][Full Text] [Related]
10. Developmental and sex-related changes of the growth hormone axis in lean and obese Zucker rats.
Leidy JW; Romano TM; Millard WJ
Neuroendocrinology; 1993; 57(2):213-23. PubMed ID: 8099719
[TBL] [Abstract][Full Text] [Related]
11. Effects of 14-day infusions of growth hormone and/or insulin-like growth factor I on the obesity of growing Zucker rats.
Dubuis JM; Deal C; Tsagaroulis P; Clark RG; Van Vliet G
Endocrinology; 1996 Jul; 137(7):2799-806. PubMed ID: 8770900
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of ethanol on the growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-I axis in the rat.
Soszynski PA; Frohman LA
Endocrinology; 1992 Dec; 131(6):2603-8. PubMed ID: 1359962
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone secretion is differently affected in genetically obese male and female rats.
Cocchi D; Parenti M; Cattaneo L; De Gennaro Colonna V; Zocchetti A; Müller EE
Neuroendocrinology; 1993 May; 57(5):928-34. PubMed ID: 8105399
[TBL] [Abstract][Full Text] [Related]
14. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II.
Ceda GP; Davis RG; Rosenfeld RG; Hoffman AR
Endocrinology; 1987 Apr; 120(4):1658-62. PubMed ID: 3104015
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone in obesity.
Scacchi M; Pincelli AI; Cavagnini F
Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
17. Dynamic of the GRF-induced GH response in genetically obese Zucker rats: influence of central and peripheral factors.
Renier G; Gaudreau P; Deslauriers N; Petitclerc D; Brazeau P
Regul Pept; 1990 Mar; 28(1):95-106. PubMed ID: 2139233
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the hypothalamo-pituitary-IGF-I axis in rats made obese by overfeeding.
Cattaneo L; De Gennaro Colonna V; Zoli M; Müller E; Cocchi D
J Endocrinol; 1996 Feb; 148(2):347-53. PubMed ID: 8699149
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.
Doi N; Hirotani C; Ukai K; Shimada O; Okuno T; Kurasaki S; Kiyofuji T; Ikegami R; Futamata M; Nakagawa T; Ase K; Chihara K
Arzneimittelforschung; 2004; 54(12):857-67. PubMed ID: 15646370
[TBL] [Abstract][Full Text] [Related]
20. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
